Adam Elsesser is the Chief Executive Officer and President of PENUMBRA INC, a global healthcare company focused on innovative medical devices. With a strong background in engineering and business, Elsesser has been instrumental in guiding PENUMBRA INC to become a leader in the medical device industry. He co-founded the company in 2004 and has since served as its CEO and President, overseeing its growth and development. Under Elsesser's leadership, PENUMBRA INC has made significant strides in developing and commercializing novel technologies for the treatment of vascular diseases. One of the company's most notable achievements is the development of the Penumbra System, a minimally invasive thrombectomy device used to treat acute ischemic stroke. This groundbreaking technology has revolutionized stroke treatment and earned PENUMBRA INC widespread recognition in the medical community. Elsesser's vision and strategic direction have been key factors in the company's success, as he has consistently prioritized innovation and patient care. As CEO and President, Adam Elsesser plays a crucial role in shaping PENUMBRA INC's corporate strategy and fostering a culture of innovation. He works closely with the company's leadership team to identify new opportunities for growth and to ensure that PENUMBRA INC remains at the forefront of medical technology. Elsesser's dedication to improving patient outcomes and his ability to navigate the complex healthcare landscape have solidified his position as a respected leader in the industry.